J05 Interim results from cohort 1 of the double-blind, dose-escalation phase I/II clinical trial of amt-130 (HD-genetrx-1) for early-stage huntington’s disease (HD)
E. Furr Stimming, V. Sung, C. Testa, S. Kostyk, C. Ross, A. Samii, M. Geschwind, Deborah Hall, P. Dayalu, R. Lonser, Brad Elder, P. Larson, David L. Cooper, Marcie Clarkin, T. Ali, R. Dolmetsch
{"title":"J05 Interim results from cohort 1 of the double-blind, dose-escalation phase I/II clinical trial of amt-130 (HD-genetrx-1) for early-stage huntington’s disease (HD)","authors":"E. Furr Stimming, V. Sung, C. Testa, S. Kostyk, C. Ross, A. Samii, M. Geschwind, Deborah Hall, P. Dayalu, R. Lonser, Brad Elder, P. Larson, David L. Cooper, Marcie Clarkin, T. Ali, R. Dolmetsch","doi":"10.1136/jnnp-2022-ehdn.255","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":251913,"journal":{"name":"J: Clinical therapeutics","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"J: Clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2022-ehdn.255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
